Biohit Oyj
Manufacturing · Finland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Laippatie 1, Helsinki, FinlandWebsite
www.biohit.fiRevenue
<$5 MillionIndustry
About Biohit Oyj
Biohit Oyj Org Chart
Is Biohit Oyj your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Biohit Oyj, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Biohit Oyj has new funding data
Product Launch: Get notified when Biohit Oyj launches new products
Earning: See what the market has to say on Biohit Oyj recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Biohit Oyj
Check out if Biohit Oyj is spiking on competitors!
Check if Biohit Oyj has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if Biohit Oyj had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Biohit Oyj as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Biohit Oyj is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biohit Oyj is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biohit Oyj.
Biohit Oyj News & Media
Biohit Oyj: Notification Pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act
Biohit Oyj: Notification Pursuant to Chapter 9, Section 10 of the Finnish Securities Markets ActBiohit Oyj Stock Exchange Release, 6 November 2025 at 9:50 a.m. (EET)Biohit Oyj has on 5 November 2025 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act, acco…TPX Medik appointed as the exclusive distributor of GastroPanel® test in Malaysia
Biohit Oyj press release 14.12.2020 at 9.30 local time (EEST) Biohit Oyj and TPX Medik (Selangor, Malaysia) have signed a contract on the exclusive rights for distribution of Biohit GastroPanel® test in Malaysia. This is a major milestone in the global expansion strategy of Biohit Oyj, its flagship test now entering into the growing market of Malaysia. GastroPanel[®] biomarker test is a unique innovation of Biohit Oyj, designed for the first-line diagnosis of allBiohit Oyj’s Financial Reporting and Annual General Meeting in 2021
Biohit Oyj Financial calendar, December 09, 2020 at 4:30 pm local time (EET) · Biohit Oyj will release its financial statements for 2020 on Wednesday 17[th] of February 2021 at 9:30 am. · The Annual Report, which contains the Financial Statements for 2020 and the Report of the Board of Directors, will be published approximately during week 12. · Biohit Oyj’s Annual General Meeting has been planned for Wednesday 21[th] of April 2021 at 5:00Biohit GastroPanel[®] test was studied clinically in patients with autoimmune disease
Press release 25.09.2020 at 15.00 local time (EEST) This study was completed at the Outpatient Department of Internal Medicine (Oulu University Hospital), and the report of the results was recently accepted for publication in an international gastroenterology journal (1). At the moment endoscopic services have been severely curtailed due to the COVID-19 pandemic. This further increases the risk of patients with autoimmune disease developing autoimmune atrophic gastritis (AAG) and even gastric ca
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biohit Oyj
Biohit specializes in innovative health solutions, offering a range of laboratory tests and medical devices, including the GastroPanel and various quick tests for gastrointestinal health. Their products are designed for healthcare professionals and laboratories, focusing on diagnostics related to conditions such as celiac disease, lactose intoleran... Read More